|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
about 14 years ago
Emerging Pharma Leaders 2012about 14 years ago
Who Will Pay for New Drugs?about 14 years ago
Less, But Betterabout 14 years ago
John Lechleiter on PhRMA and Innovationabout 14 years ago
Today's Mission Critical: Making Sense of Spending on Clinical Trialsabout 14 years ago
The Learning Curveabout 14 years ago
Marketing: Why the Conversation Has Changed — ForeverAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
3
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
4
Pharmaceutical Executive Daily: FDA Approves Zanvastro
5